NCT05369585View on ClinicalTrials.gov

Mode of Action (MoA) Study of TOTUM-63 in Individuals at Increased Cardio-metabolic Risk

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 25, 2022

Primary Completion Date

April 12, 2023

Study Completion Date

April 12, 2023

Conditions
Prediabetic StateDysglycemiaOverweight and Obesity
Interventions
DIETARY_SUPPLEMENT

TOTUM-63

5-g per day dose of TOTUM-63 supplement, a mix of 5 plant extracts. Daily dose for 8 weeks followed by a 4 weeks follow-up period without supplementation.

Trial Locations (1)

G1V 0A6

Institute of Nutrition and Funtional Foods (INAF) - Laval University, Québec

All Listed Sponsors
collaborator

Laval University

OTHER

collaborator

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

OTHER

collaborator

Valbiotis Canada inc.

UNKNOWN

lead

Valbiotis

INDUSTRY